Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden-Reference-Cited by-同舟云学术

Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden

Published:2000-04 Issue:4 Volume:17 Page:299-307
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet Med

Author:

Hedblad B.,Nilsson P.,Janzon L.,Berglund G.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1464-5491.2000.00280.x/fullpdf

Reference48 articles.

1. The Impact of Insulin Upon Atherosclerosis

2. Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease

3. Is Insulin Really a Heart Disease Risk Factor?

4. Associations Between Insulin Levels and Cardiovascular Disease Are Confounded by Comorbidity

5. Development of the Multiple Metabolic Syndrome: An Epidemiologic Perspective

Cited by 294 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of triglyceride-glucose index with severity of coronary artery disease among male patients;Scientific Reports;2024-09-02

2. Deficiency of Peptidylglycine-alpha-amidating Monooxygenase, a Cause of Sarcopenic Diabetes Mellitus;The Journal of Clinical Endocrinology & Metabolism;2024-08-13

3. Lifestyle and genetic risk of chronic liver disease in metabolically healthy and unhealthy individuals from the general population;JHEP Reports;2024-08

4. Novel Plasma Biomarkers Associated with Future Peripheral Atherosclerotic Disease and Abdominal Aortic Aneurysm—Insights from Contemporary Prospective Studies from the Malmö Diet and Cancer Study;Biomolecules;2024-07-13

5. The Effects of Flaxseed Consumption on Glycemic Control in Native American Postmenopausal Women with Hyperglycemia and Hyperlipidemia;Healthcare;2024-07-11